Dopamine D2 receptor gene variants

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090104598A1
SERIAL NO

11407330

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a method of predicting antipsychotic response to drug therapy comprising testing a sample obtained from a subject for the presence of a polymorphism in the dopamine D2 receptor gene DRD2, wherein the presence of the rs1079598T allele, the rs1125394A allele or both is predictive of the subject being susceptible to drug therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE FOR ADDICTION AND MENTAL HEALTH100 STOKES STREET BELL GATEWAY BUILDING 6TH FLOOR TORONTO M6J 1H4

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hwang, Rudi Toronto, CA 1 1
Kennedy, James L Toronto, CA 21 138

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation